Clinical trial
A Phase II Study of Fractionated CyberKnife Stereotactic Radiosurgery to Perioptic Tumors
NCT02225197 is registered in ClinicalTrials.gov with Community Cancer Center, Normal, Illinois as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Fractionated CyberKnife Stereotactic Radiosurgery to Perioptic Tumors
- Lead sponsor
- Community Cancer Center, Normal, Illinois
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- October 31, 2017
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tumor, benign, optic nerve